Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	0,00 %	0,00 %	-96,94 %

Company Profile for GreenLight Biosciences Holdings Share

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

Company Data

Name GreenLight Biosciences Holdings

Company GreenLight Biosciences Holdings

Symbol GRNA

Website https://greenlightbiosciences.com

Primary Exchange

NASDAQ

ISIN US39536G1058

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Dr. Andrey Juan Zarur Ph.D.

Market Capitalization 45 Mio

Country United States of America

Currency USD

Employees 0,3 T

Address 200 Boston Avenue, 02155 Medford

IPO Date 2022-02-03

ID Changes

Date	From	To
03.02.2022	ENVI	GRNA

Ticker Symbols

Name	Symbol
NASDAQ	GRNA

More Shares

Investors who GreenLight Biosciences Holdings hold also have the following shares in their portfolio:

LB.HESS.THR.CARRARA05S/23 Bond

TURKEY 06/36 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog